I migliori medici di Immunoterapia per il carcinoma della mammella in Turchia — TOP-23 medici

Il medico è un oncologo medico turco altamente esperto, specializzato in sarcoma, linfoma, cancro al pancreas, polmone e seno. Con oltre 20 anni di esperienza, il medico si concentra sulla biologia dei tumori, l'immunologia dei tumori, l'immunoterapia del cancro e le terapie mirate. Dal 2019, il medico lavora come oncologo medico presso il Centro Medico Anadolu e ha precedentemente ricoperto ruoli di leadership presso la Facoltà di Medicina dell'Università Okan di Istanbul e l'Ospedale di Formazione GATA Haydarpaşa. Il medico è autore di oltre 40 pubblicazioni nella ricerca sul cancro ed è membro dell'Associazione Turca di Oncologia Medica e della Società Europea di Testa e Collo.<\/p>

Il Dott. Solak è specializzato nel trattamento del cancro al seno con un fellowship presso l'Hacettepe University Cancer Institute, uno dei principali centri oncologici della Turchia.

• Formato presso il The University of Texas MD Anderson Cancer Center
• Gestisce casi complessi, inclusi i tumori ovarici e gastrointestinali
• Residenza completata presso l'Istanbul Sisli Etfal Training and Research Hospital
• Focalizzato sull'immunoterapia per vari tipi di cancro

La Dott.ssa Eda Tanrikulu è specializzata in oncologia medica e chemioterapia presso l'Anadolu Medical Center, con un forte focus sull'immunoterapia per il cancro al seno.

• Ha completato la formazione in oncologia medica presso l'Università di Marmara
• Terzo posto in Turchia nell'esame per specialità minori
• Ha guidato studi clinici internazionali in oncologia medica
• Ex capo dell'unità di oncologia medica presso il Haydarpaşa Numune Training and Research Hospital

Dr. Sezer Sağlam is a medical oncologist at Gayrettepe Florence Nightingale Hospital in Istanbul. He specializes in gastrointestinal oncology and the treatment of liver cancer. Dr. Sağlam was nominated for the International Best Researcher Award for his work on liver-transplanted patients. He has served as a professor of medical oncology since 2016.

• Member of the European Society for Medical Oncology (ESMO).
• Active member of the American Society of Clinical Oncology (ASCO).
• Member of the European Neuroendocrine Tumor Society (ENETS).
• Works at JCI-accredited facility with advanced PET-MRI and radiology departments.

Dr. Emine Yildirim is an associate professor of general surgery at Atlas University Hospital, Istanbul. She specializes in surgical oncology with a focus on breast cancer treatment and reconstruction. Dr. Yildirim has published over 15 scientific articles in peer-reviewed journals like Academic Radiology. She holds multiple international certificates in breast cancer surgery and nipple-sparing techniques.

• Performs breast-conserving surgery, free flap reconstruction, and implant-based breast augmentation.
• Treats complex oncological conditions including thyroid, bladder, and colorectal cancers.
• Completed medical residency at Istanbul Haseki Health Application and Research Center.
• Works at AACI-accredited Atlas University Hospital, which treats 565,000 patients annually.

Dr. Abdullah Sakin is a medical oncologist at Medipol Bahçelievler University Hospital in Istanbul. He specializes in treating complex cancers, including lung, breast, and gastrointestinal malignancies. Dr. Sakin previously served as the Head of the Medical Oncology Department at Yüzüncü Yıl University. He also held a leadership role at Prof. Dr. Cemil Taşçıoğlu City Hospital.

• Provides immunotherapy, biological therapy, and hormone treatments for various cancer types.
• Treats rare and difficult conditions like thymoma, chordoma, and Ewing's sarcoma.
• Performs PET-CT scans and comprehensive oncological check-ups for men and women.
• Uses JCI-accredited facilities with systems like TrueBeam STx and Halcyon for treatment.

Il dottor Sinan Karaaslan è specializzato in tumori del seno, colon-rettali e urogenitali, con una vasta esperienza in immunoterapia presso l'Anadolu Medical Center.

• Oltre 10 anni di esperienza focalizzati sull'oncologia medica
• Formatosi presso la Facoltà di Medicina Cerrahpaşa dell'Università di Istanbul
• Membro della Società Turca di Oncologia Medica
• Lavora in un ospedale leader accreditato dalla JCI

La Professoressa Yesim Yildirim si specializza in immunoterapia del cancro per il tumore al seno, con oltre 80 pubblicazioni internazionali e libri medici co-autorizzati.

• Membro della Società Europea di Oncologia Medica (ESMO)
• Oltre un decennio di esperienza presso il Centro Medico Anadolu
• Formata in istituzioni prestigiose, tra cui il Rambam Medical Centre e il Mount Vernon Cancer Center
• Professoressa presso l'Università Haliç, combina la pratica clinica con la ricerca accademica

Il medico è un oncologo medico e mammario certificato ECFMG e ESMO con oltre 20 anni di esperienza, specializzato nel trattamento del cancro solido, del cancro al seno, del colon-retto e del polmone. Dal 2016, il medico è specialista in oncologia medica presso l'Anadolu Medical Center.<\/p>

Il medico si è laureato presso l'Accademia Medica Militare di Gülhane con una laurea in medicina generale e ha completato specializzazioni in oncologia interna e medica. Il medico è stato professore e professore associato presso l'Accademia Medica Militare di Gülhane, contribuendo in modo significativo all'educazione medica.<\/p>

Con oltre 110 articoli sulla gestione del cancro, il medico è membro di diverse prestigiose organizzazioni oncologiche.<\/p>

Il medico si è laureato presso la Facoltà di Medicina dell'Università di Ankara e ha completato la formazione in medicina interna presso la Scuola di Medicina di Ankara GATA. Specializzandosi in oncologia medica e ematologia, il medico ha completato una borsa di studio clinica negli Stati Uniti. Pioniere in Turchia, il medico ha fatto parte del team che ha eseguito il primo trapianto di midollo osseo nel paese. Il medico ha servito come docente ospite in istituzioni prestigiose a Londra e in Svizzera. In possesso del Certificato Europeo di Oncologia Medica, il medico è membro fondatore sia della Società Turca di Oncologia Medica che del Gruppo Oncologico Turco. Il focus clinico include tumori al seno, gastrointestinali, polmonari, linfomi e mieloma.<\/p>

Dr. Sezer Saglam is a medical oncologist at Gayrettepe Florence Nightingale Hospital in Istanbul. He specializes in treating gastrointestinal and breast cancers. His research on rectal cancer timing has influenced global treatment protocols. Dr. Saglam develops personalized therapy plans using targeted medicine and precision techniques.

• Nominated for the International Best Researcher Award for work on liver cancer.
• Leads clinical trials focused on targeted therapies and precision oncology.
• Member of the American Society of Clinical Oncology (ASCO).
• Certified by the European Society for Medical Oncology (ESMO).

Il medico è un oncologo specializzato nel trattamento dei tumori al seno, ai polmoni e gastrointestinali. Attualmente, il medico pratica presso l'Ospedale Universitario Istinye Liv.

Con una carriera che si estende su molteplici istituzioni prestigiose, il medico ha servito come Specialista in Medicina Interna presso l'Ospedale Statale di Malatya, medico presso la Clinica Oncologica di Ankara e membro del Dipartimento di Oncologia presso l'Ospedale Regionale di Formazione e Ricerca di Erzurum.

Il medico si è laureato presso la Facoltà di Medicina dell'Università di Selcuk e ha ottenuto il titolo di Professore Associato nel 2016.

Education & Expertise

• 1998 to 2004 – Istanbul University, Istanbul Faculty of Medicine
• 2005 to 2009 – Düzce University, Internal Medicine Specialization
• 2009 to 2010 – Beytüşşebap State Hospital, Compulsory Internal Medicine Service
• 2010 to 2013 – Bülent Ecevit University, Medical Oncology Specialization
• 2013 to 2015 – Recep Tayyip Erdoğan University, Medical Oncology Compulsory Service
• 2015 to Present – Associate Professor, Recep Tayyip Erdoğan University
• 2015 to 2021 – Lecturer, Medical Oncology, Sakarya University Faculty of Medicine
• 2020 to Present – Professor, Sakarya University Faculty of Medicine
• 2020 to Present – Ph.D. Student, Inorganic Chemistry, Sakarya University

Experience

• 2008 – Cleveland Clinic, Rheumatology & Gastroenterology Rotation
• 2016 to 2017 – Northeastern University, The Center for Pharmaceutical Biotechnology and Nanomedicine, Boston, U.S.

Professional Memberships

• TTOD (Turkish Society of Medical Oncology)
• ASCO (American Society of Clinical Oncology)
• ESMO (European Society for Medical Oncology)

Education and Specialization

• 2006: Kocaeli University Faculty of Medicine
• 2014: Akdeniz University Faculty of Medicine, Internal Medicine
• 2018: Akdeniz University Faculty of Medicine, Medical Oncology

Experience

• 2006 - 2008: Konya Derebucak District Hospital
• 2009 - 2015: Akdeniz University Hospital
• 2015: Antalya Kaş State Hospital
• 2015 - 2016: İnönü University Faculty of Medicine
• 2016 - 2021: Akdeniz University Hospital
• 2021 - 2023: Antalya Training and Research Hospital

Dr. Muhammed Mustafa Atci is an Associate Professor of Medical Oncology at İstinye University, Liv Hospital Topkapı (2025–present). He previously served as Associate Professor and Education Coordinator at Prof. Dr. Cemil Taşcıoğlu City Hospital (2023–2025). He was also a Medical Oncologist there (2018–2021).

He has been a member of ASCO and the Turkish Society of Medical Oncology since 2018. He is the author or co-author of 19 peer-reviewed international papers on colon, breast, gastric, pancreatic, lung, thyroid, sarcoma, and colorectal cancers.

Notable works include a multicentre study on stage IIB colon cancer survival (Journal of Chemotherapy). He also studied the De Ritis ratio for lung metastasis in testicular cancer (Current Urology). His prognostic studies used PET/CT, MSI, lymph node ratio, and metabolic tumor volume.

Assoc. Prof. Ayşe İrem Yasin, M.D., is a medical oncologist who specializes in solid tumors. Her clinical focus includes breast, lung, gastrointestinal, gynecologic, and urologic cancers. She also treats brain and other CNS tumors, soft tissue sarcomas, head and neck cancers, adenocarcinomas, melanoma, Merkel cell carcinoma, and cancers of unknown primary. She practices at Medipol Acıbadem District Hospital (2025–present). She previously worked at Şişli Etfal Training and Research Hospital (2023–2025).

She completed a Medical Oncology fellowship at Bezmialem Vakıf University (2019–2022). This followed an Internal Medicine residency at the same institution (2012–2016). Her international experience includes the Breast Cancer Unit at the University of Piemonte Orientale in Novara (2022). She also trained at Basel University Hospital, Cleveland Clinic, and Harvard Medical School. She holds the ESMO Board Certificate (2022).

Dr. Irfan Cicin is a Professor of Medical Oncology at the Trakya University Faculty of Medicine (2015–present). He has over 20 years of medical oncology experience and has held academic roles since 2010.

Education: MD, Istanbul University – Cerrahpaşa (1991–1997). Residency in Internal Medicine, Trakya University (1997–2002). Fellowship in Medical Oncology, Trakya University (2002–2004).

Practice: Medical Oncologist, Trakya University (2005–2008). Medical Oncologist, Elazığ Training and Research Hospital (2008–2010). Associate Professor of Medical Oncology, Trakya University (2010–2015). He previously served as a physician in the Turkish Air Force at Etimesgut Military Hospital (2004–2005).

Assoc. Prof. Atakan Topçu, M.D., is a medical oncologist at Medipol University and Medipol Acıbadem Regional Hospital. He treats solid tumors, including lung, breast, colorectal, gastric, and neuroendocrine cancers. His work also covers targeted therapies, immunotherapy, geriatric oncology, and cancer-related malnutrition, cachexia, and sarcopenia.

He has authored more than 50 peer-reviewed papers. Recent work includes a 2024 Frontiers in Medicine study on geriatric syndromes and a 2023 Future Oncology paper on sarcopenia and anxiety in lung cancer. He has also published on the CONUT score in breast cancer and on malnutrition in HER2-negative metastatic gastric cancer.

Dr. Topçu serves on the Editorial Board of BMC Cancer. He is a member of the Turkish Society of Medical Oncology, ESMO, and the Turkish Geriatrics Society. Education and training: M.D., Uludağ University; residency in Internal Medicine, Marmara University; fellowship in Medical Oncology, Bezmialem Vakıf University.

Dr. Ercan Ozden is a specialist in internal medicine and medical oncology. He earned his medical degree and completed his residency at Istanbul University, Cerrahpaşa Faculty of Medicine. He later received a subspecialty in medical oncology at Kocaeli University Faculty of Medicine from 2016 to 2020.

Dr. Ozden has worked in medical oncology at Şırnak State Hospital. He has also served as an internal medicine specialist at Bağcılar Private Safa Hospital and Küçükçekmece Batı Bahat Hospital. He has extensive clinical experience in both internal medicine and oncology.

Dr. Nail Paksoy is an associate professor of medical oncology at Medipol Bahçelievler Hospital. He is board-certified by the European Society for Medical Oncology (ESMO). Dr. Paksoy specializes in lung, breast, and gastrointestinal cancers. He uses modern immunotherapy and targeted therapy protocols. His clinic is JCI-accredited for high safety standards.

• Served as a subinvestigator in over 8 international clinical trials for Roche and Pfizer.
• Authored over 40 research articles in journals indexed by SCI and SSCI.
• Completed dual fellowships in allergy-immunology and medical oncology.
• Treats complex sarcomas and renal cell carcinomas with systemic therapies.